Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
暂无分享,去创建一个
C. Rudin | Z. Kan | S. Seshagiri | K. Pujara | T. Januario | J. Stinson | T. Holcomb | F. D. de Sauvage | J. Bazan | T. Tang | R. Yauch | B. Alicke | S. Gould | G. J. Dijkgraaf | C. Hann | C. Ahn | C. Callahan | J. Low | Christina P. Ahn | C. L. Hann | C. M. Rudin | J. F. Bazan | R. L. Yauch | G. J. P. Dijkgraaf | B. Alicke | T. Januario | C. P. Ahn | T. Holcomb | K. Pujara | J. Stinson | C. A. Callahan | T. Tang | Z. Kan | S. Seshagiri | S. E. Gould | J. A. Low | F. J. de Sauvage | Kanan D. Pujara | Thomas Holcomb | Zhengyan Kan | G. Dijkgraaf | Jeremy Stinson
[1] Helen Baines,et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. , 2004, Cancer cell.
[2] S. Rasmussen,et al. The structure and function of G-protein-coupled receptors , 2009, Nature.
[3] L. Prézeau,et al. Allosteric modulators of class-C G-protein-coupled receptors open new possibilities for therapeutic application , 2004 .
[4] Mark G. F. Sun,et al. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade , 2009, Proceedings of the National Academy of Sciences.
[5] Raoul Tibes,et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. , 2009, The New England journal of medicine.
[6] L. Rubin,et al. The hedgehog pathway and neurological disorders. , 2006, Annual review of neuroscience.
[7] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[8] Jeremy Stinson,et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. , 2009, The New England journal of medicine.
[9] Q. Gu,et al. Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.
[10] N. Tarbell,et al. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification , 2007, Nature Clinical Practice Oncology.
[11] Jussi Taipale,et al. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. , 2002, Genes & development.
[12] M. Scott,et al. Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.
[13] L. Siu,et al. First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting , 2008, Journal of hematology & oncology.
[14] Lee L. Rubin,et al. Targeting the Hedgehog pathway in cancer , 2006, Nature Reviews Drug Discovery.
[15] J. Gutkind,et al. G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.
[16] M. Scott,et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine , 2000, Nature.